This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hahn, M. A. Articles by Pfeifer, G. P. Search for Related Content PubMed PubMed Citation Articles by Hahn, M. A. Articles by Pfeifer, G. P.

Methylation of Polycomb Target Genes in Intestinal Cancer Is Mediated by Inflammation

¹ Division of Biology and ² Department of Radiation Biology, Beckman Research Institute of the City of Hope, Duarte, California

Requests for reprints: Gerd P. Pfeifer, Division of Biology, Beckman Research Institute, City of Hope, 1500 East Duarte Road, Duarte, CA 91010. Phone: 626-301-8853; Fax: 626-358-7703; E-mail: gpfeifer{at}coh.org.

Key Words: DNA methylation • Inflammation • Polycomb

Epigenetic changes are strongly associated with cancer development. DNA hypermethylation is associated with gene silencing and is often observed in CpG islands. Recently, it was suggested that aberrant CpG island methylation in tumors is directed by Polycomb (PcG) proteins. However, specific mechanisms responsible for methylation of PcG target genes in cancer are not known. Chronic infection and inflammation contribute to up to 25% of all cancers worldwide. Using glutathione peroxidase, Gpx1 and Gpx2, double knockout (Gpx1/2-KO) mice as a model of inflammatory bowel disease predisposing to intestinal cancer, we analyzed genome-wide DNA methylation in the mouse ileum during chronic inflammation, aging, and cancer. We found that inflammation leads to aberrant DNA methylation in PcG target genes, with 70% of the 250 genes methylated in the inflamed tissue being PcG targets in embryonic stem cells and 59% of the methylated genes being marked by H3K27 trimethylation in the ileum of adult wild-type mice. Acquisition of DNA methylation at CpG islands in the ileum of Gpx1/2-KO mice frequently correlates with loss of H3K27 trimethylation at the same loci. Inflammation-associated DNA methylation occurs preferentially in tissue-specific silent genes and, importantly, is much more frequently represented in tumors than is age-dependent DNA methylation. Sixty percent of aberrant methylation found in tumors is also present in the inflamed tissue. In summary, inflammation creates a signature of aberrant DNA methylation, which is observed later in the malignant tissue and is directed by the PcG complex. [Cancer Res 2008;68(24):10280–9]

This article has been cited by other articles:

				H. Takeshima, S. Yamashita, T. Shimazu, T. Niwa, and T. Ushijima The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands Genome Res., November 1, 2009; 19(11): 1974 - 1982. [Abstract] [Full Text] [PDF]

				S. Yamashita, K. Hosoya, K. Gyobu, H. Takeshima, and T. Ushijima Development of a Novel Output Value for Quantitative Assessment in Methylated DNA Immunoprecipitation-CpG Island Microarray Analysis DNA Res, October 1, 2009; 16(5): 275 - 286. [Abstract] [Full Text] [PDF]

				H. Sim, B. Hu, and M. S. Viapiano Reduced Expression of the Hyaluronan and Proteoglycan Link Proteins in Malignant Gliomas J. Biol. Chem., September 25, 2009; 284(39): 26547 - 26556. [Abstract] [Full Text] [PDF]

				W. G. Nelson, A. M. De Marzo, and S. Yegnasubramanian Epigenetic Alterations in Human Prostate Cancers Endocrinology, September 1, 2009; 150(9): 3991 - 4002. [Abstract] [Full Text] [PDF]

				M. T. McCabe, J. C. Brandes, and P. M. Vertino Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications Clin. Cancer Res., June 15, 2009; 15(12): 3927 - 3937. [Abstract] [Full Text] [PDF]